Actions and Detail Panel
Biotech and Money Cross-Border M&A Bootcamp
Thu 14 September 2017, 09:30 – 17:00 BST
In line with our mission to address the funding, financing and investment challenges of the world’s most innovative healthcare companies, Biotech and Money is teaming up with some of the world’s foremost experts, advisers, bankers and consultants to help CEOs and CFOs navigate the how, what, where and when of successful Cross-Border M&A.
The key USPs are the very high level and caliber of attendee and program, exclusivity, and the personalised approach. In addition to ‘no holds barred’ discussions, it will feature tailored sessions, where each registering company will receive individual attention from the experts to talk through strategy, tactics, mechanics and ideas unique to them.
What can you expect?
Life science and healthcare company specific M&A advice
Multi-dimensional and world class experts leading sessions
Independent, Chatham House and ‘No holds barred’ roundtables and panel discussions
1-2-1 time with experts to review your unique position and strategy
Invite only, highly exclusive and open only to 8 companies
Drinks and Dinner reception, offering best in class networking opportunity
CEOs and CFOs only
One stop shop
Hear from CEO’s of recent M&A successes and failures
Structure and Formats:
9.00am - Breakfast
- Keynote address: The current state of the deal environment
- Anatomy of an M&A: Back to back case study discussions of M&As.
- Determining and defining your M&A strategy: before and during the deal
- Managing risks in cross-border transactions
- After the deal: the importance of effective integration
- Financial PR and communications
- Banks, advisors, and investors
- Regulatory requirements and M&A checklists
- 1-2-1 Meetings with all advisors
5.00pm - Close
5.30pm - 7.00pm - Drinks Reception @ 2017 Assembly and Awards Dinner
7.00pm - Optional attendance to 2017 Assembly and Awards Dinner (separate ticket to be purchased)
Nb. Registrations are strictly limited to CEOs, and where appropriate CFOs of listed, and soon to be listed life science and healthcare companies. Biotech and Money holds the right to cancel and refund any registration that does not meet our vetting criteria.